Sequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and integrated capabilities across the global pharmaceutical market. The merger will expand Sequent's capital base and is expected to enhance marketing presence, facilitate backward integration, and create procurement synergies.
